Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rimi Izumihara"'
Autor:
Rimi Izumihara, Hiroshi Nomoto, Kenichi Kito, Yuki Yamauchi, Kazuno Omori, Yui Shibayama, Shingo Yanagiya, Aika Miya, Hiraku Kameda, Kyu Yong Cho, So Nagai, Ichiro Sakuma, Akinobu Nakamura, Tatsuya Atsumi
Publikováno v:
Diabetes & Metabolism Journal, Vol 48, Iss 3, Pp 473-481 (2024)
Background Fibrates have renal toxicity limiting their use in subjects with chronic kidney disease (CKD). However, pemafibrate has fewer toxic effects on renal function. In the present analysis, we evaluated the effects of pemafibrate on the renal fu
Externí odkaz:
https://doaj.org/article/434fc40dd96546bfba539ebd70216bbd
Autor:
Yuki Oe, Hiroshi Nomoto, Akinobu Nakamura, Saki Kuwabara, Yuka Takahashi, Ayano Yasui, Rimi Izumihara, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, Hideaki Miyoshi
Publikováno v:
Journal of Diabetes Research, Vol 2022 (2022)
Incretins reduce glycemic variability (GV) in patients with type 2 diabetes, but it is unknown whether switching from a combination of basal insulin and a DPP-4 inhibitor to insulin degludec/liraglutide (IDegLira) improves GV. We performed an explora
Externí odkaz:
https://doaj.org/article/95d254e3cb694b1fabb0ca8ce6bf496b
Autor:
null Yuka Takahashi, null Hiroshi Nomoto, null Hiroki Yokoyama, null Yoshinari Takano, null So Nagai, null Atsushi Tsuzuki, null Kyu Yong Cho, null Aika Miya, null Hiraku Kameda, null Jun Takeuchi, null Shinji Taneda, null Yoshio Kurihara, null Tatsuya Atsumi, null Akinobu Nakamura, null Hideaki Miyoshi, null Yuka Hamaya, null Asuka Miyazaki, null Kento Nakata, null Rimi Izumihara, null Risa Kamigaki, null Kazuhisa Tsuchida, null Kyu‐Yong Cho, null Hiromichi Kijima, null SWITCH‐SEMA 1 study group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee3eaab58f62aedb0e1730d8bb4ceee1
https://doi.org/10.1111/dom.14998/v2/response1
https://doi.org/10.1111/dom.14998/v2/response1
Autor:
KOKI CHIBA, HIROSHI NOMOTO, RIMI IZUMIHARA, HIRAKU KAMEDA, KYUYONG CHO, HIDEAKI MIYOSHI, TATSUYA ATSUMI
Publikováno v:
Diabetes. 71
Background: In pancreatic β-cells under diabetic conditions, metabolic stressors cause mitochondrial dysfunction and reduce oxidative phosphorylation, resulting in impaired intracellular metabolism. It has been suggested that aberrant activation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e2c3496aae708423c25b0cd3eef318c
https://doi.org/10.2337/db22-1462-p
https://doi.org/10.2337/db22-1462-p
Autor:
RIMI IZUMIHARA, HIROSHI NOMOTO, KOKI CHIBA, HIRAKU KAMEDA, KYUYONG CHO, AKINOBU NAKAMURA, HIDEAKI MIYOSHI, HIROKI MIZUKAMI, TATSUYA ATSUMI
Publikováno v:
Diabetes. 71
Background and Aims: It has been shown that metabolic remodeling from oxidative phosphorylation to glycolysis via activation of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) occurs in pancreatic beta cells in non-Asians with diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::564e6ebba09c4ad597e7065c86a9a5e2
https://doi.org/10.2337/db22-1465-p
https://doi.org/10.2337/db22-1465-p
Autor:
Rimi Izumihara, Kazuhide Tanimura, Tatsuya Atsumi, Keita Ninagawa, Tomohiro Shimizu, Toshiyuki Hattori, Masaru Kato, Hiroshi Nomoto
Publikováno v:
Journal of bone and mineral metabolism. 38(6)
Hypophosphatasia (HPP) is caused by mutations in the tissue nonspecific alkaline phosphatase (TNSALP) gene in an autosomal recessive or dominant manner and characterized by defective mineralization of bone and low serum ALP levels. In this report, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98a916ad60ab804ed4ac8c860ff39d0e
https://pubmed.ncbi.nlm.nih.gov/32772198
https://pubmed.ncbi.nlm.nih.gov/32772198
Autor:
Wataru Ono, Rimi Izumihara, Kyuon Cho, Yuki Ohe, Ikumi Shigesawa, Koki Chiba, Hiraku Kameda, Reina Kameda, Risa Kamigaki, Hideaki Miyoshi, Hiroshi Iesaka, Hiroshi Nomoto, Akinobu Nakamura, Tatsuya Atsumi
Publikováno v:
Journal of the Endocrine Society
BACKGROUND: Cyclic Cushing’s disease is rare and treatments have not been established for post-surgical recurrent cases. Here, we report a patient with recurrent cyclic Cushing’s disease, whose subjective symptoms improved by administration of me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceca200a09cd315e2b1b53bab1bbf0bd
https://doi.org/10.1210/jendso/bvaa046.490
https://doi.org/10.1210/jendso/bvaa046.490